Finance
MTNB’s Debt-to-Equity Ratio at 0.43: What It Means for Matinas Biopharma Holdings Inc’s Future
The market performance of Matinas Biopharma Holdings Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $9.60 on 07/16/24, while the lowest value for the same duration was $0.47 on 04/08/25. 52-week price history
